Pleiotropic vasoprotective effects of high-dose atorvastatin therapy in the context of achieving the target low-density lipoprotein cholesterol in patients after myocardial infarction
Aim. To study the lipid-lowering and pleiotropic vasoprotective effects of atorvastatin depending on the achievement of the target low-density lipoprotein cholesterol (LDL-C) level in patients after ST-segment elevation myocardial infarction (STEMI) within 48-week follow-up period.Material and metho...
Saved in:
| Main Authors: | L. I. Salyamova, A. A. Khromova, O. G. Kvasova, K. N. Korenkova, K. N. Polezhaeva, N. A. Donetskaya, K. I. Pavlenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2022-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3157 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined lipid lowering therapy, including ezetimibe, in the post-infarction period
by: V. E. Oleynikov, et al.
Published: (2024-05-01) -
Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01) -
Correlation analysis of serum small and dense low-density lipoprotein cholesterol and carotid intima-media thickness in maintenance hemodialysis patients
by: KUAI Ting-ting, et al.
Published: (2020-01-01) -
Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome
by: A. A. Yalymov, et al.
Published: (1970-01-01) -
Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
by: I. A. Latfullin, et al.
Published: (2015-12-01)